Time lines of infection and disease in human influenza: A review of volunteer challenge studies

被引:838
作者
Carrat, Fabrice [1 ,2 ,3 ]
Vergu, Elisabeta [1 ,2 ,4 ]
Ferguson, Neil M. [5 ]
Lemaitre, Magali [1 ,2 ]
Cauchemez, Simon [5 ]
Leach, Steve [6 ]
Valleron, Alain-Jacques [1 ,2 ,3 ]
机构
[1] Univ Paris 06, UMR S 707, Fac Med St Antoine, F-75571 Paris 12, France
[2] INSERM, UMR S 707, Paris, France
[3] Hop St Antoine, AP HP, F-75571 Paris, France
[4] INRA, Math & Informat Appl Unit, Jouy En Josas, France
[5] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London, England
[6] Ctr Emergency Preparedness & Response, Hlth Protect Agcy, Salisbury, Wilts, England
基金
英国医学研究理事会;
关键词
influenza; human; signs and symptoms; virus shedding;
D O I
10.1093/aje/kwm375
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The dynamics of viral shedding and symptoms following influenza virus infection are key factors when considering epidemic control measures. The authors reviewed published studies describing the course of influenza virus infection in placebo-treated and untreated volunteers challenged with wild-type influenza virus. A total of 56 different studies with 1,280 healthy participants were considered. Viral shedding increased sharply between 0.5 and 1 day after challenge and consistently peaked on day 2. The duration of viral shedding averaged over 375 participants was 4.80 days (95% confidence interval: 4.31, 5.29). The frequency of symptomatic infection was 66.9% (95% confidence interval: 58.3, 74.5). Fever was observed in 37.0% of A/H1N1, 40.6% of A/H3N2 (p = 0.86), and 7.5% of B infections (p = 0.001). The total symptoms scores increased on day 1 and peaked on day 3. Systemic symptoms peaked on day 2. No such data exist for children or elderly subjects, but epidemiologic studies suggest that the natural history might differ. The present analysis confirms prior expert opinion on the duration of viral shedding or the frequency of asymptomatic influenza infection, extends prior knowledge on the dynamics of viral shedding and symptoms, and provides original results on the frequency of respiratory symptoms or fever.
引用
收藏
页码:775 / 785
页数:11
相关论文
共 115 条
[1]  
ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255
[2]   PREVENTION AND TREATMENT OF EXPERIMENTAL INFLUENZA-A VIRUS-INFECTION IN VOLUNTEERS WITH A NEW ANTIVIRAL ICI 130,685 [J].
ALNAKIB, W ;
HIGGINS, PG ;
WILLMAN, J ;
TYRRELL, DAJ ;
SWALLOW, DL ;
HURST, BC ;
RUSHTON, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (01) :119-129
[3]  
Arroyo M, 1975, J Antimicrob Chemother, V1, P87
[4]  
Bell D, 2006, EMERG INFECT DIS, V12, P81
[5]   RESISTANCE TO CHALLENGE WITH INFLUENZA-A HONG-KONG 123 77 (H1N1) WILD-TYPE VIRUS-INDUCED BY LIVE ATTENUATED A HONG-KONG/123 77 (H1N1) COLD-ADAPTED REASSORTANT VIRUS [J].
BETTS, RF ;
DOUGLAS, RG ;
MURPHY, BR .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (04) :744-745
[6]   COMPLEMENT IS ACTIVATED IN THE UPPER RESPIRATORY-TRACT DURING INFLUENZA-VIRUS INFECTION [J].
BJORNSON, AB ;
MELLENCAMP, MA ;
SCHIFF, GM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (05) :1062-1066
[7]   Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes [J].
Boon, ACM ;
de Mutsert, G ;
van Baarle, D ;
Smith, DJ ;
Lapedes, AS ;
Fouchier, RAM ;
Sintnicolaas, K ;
Osterhaus, ADME ;
Rimmelzwaan, GF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2453-2460
[8]  
Borroso L, 2005, ANTIVIR THER, V10, P901
[9]   Transmission of influenza A in human beings [J].
Brankston, Gabrielle ;
Gitterman, Leah ;
Hirji, Zahir ;
Lemieux, Camille ;
Gardam, Michael .
LANCET INFECTIOUS DISEASES, 2007, 7 (04) :257-265
[10]   Transmission of influenza: Implications for control in health care settings [J].
Bridges, CB ;
Kuehnert, MJ ;
Hall, CB .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) :1094-1101